Bacteria: Gram-positive

Enterococcus faecalis

General medical information for education only, not medical advice. Treatment considerations summarize published guidance at drug-class level; therapy is chosen by the treating clinician using susceptibility results, local resistance patterns and current guidelines.

Overview

A Gram-positive coccus in pairs and short chains from the gut; hardy in the healthcare environment.

Infections

Complicated and catheter-associated urinary tract infection, intra-abdominal and wound infection, bloodstream infection, endocarditis.

Signs and symptoms

Urinary infection, most often with a catheter or after a urinary procedure: painful urination, frequency, flank pain or fever. Bloodstream infection: fever and chills. Endocarditis (heart-valve infection), especially in older adults: prolonged fever, fatigue, weight loss and a new heart murmur. Wound and intra-abdominal infection: pain, swelling and fever.

Antibiotic and antimicrobial resistance

Intrinsically resistant to cephalosporins; vancomycin resistance (vanA/vanB) is less common than in E. faecium.

Treatment considerations

Ampicillin or amoxicillin when susceptible; nitrofurantoin or fosfomycin for cystitis; combination therapy for endocarditis.

Enterococcus faecalis cells in pairs and short chains, scanning electron micrograph
Enterococcus faecalis, scanning electron micrograph. CDC (J. H. Carr, P. Wardell); public domain. Image source
Gram-positive cocci in pairs and chains, schematic
Gram-positive cocci in pairs and chains. Schematic, not to scale; InnovexLab.

Sources

  1. CDC. Vancomycin-resistant Enterococci (VRE).
  2. IDSA. Complicated Urinary Tract Infections guideline.

Sources accessed November 2026. Links open external sites that InnovexLab does not control.

Medical disclaimer

This page is general educational information summarized from published public-health and professional-society guidance. It is not medical advice, a diagnosis or a treatment recommendation, and reading it does not create a clinician–patient relationship with InnovexLab. Decisions about testing, diagnosis and treatment belong to the treating clinician, using the patient’s history and examination, laboratory and susceptibility results, local resistance patterns and current guidelines. Guidance changes over time; consult the original sources for the latest version. InnovexLab provides this information as is and does not warrant that it is complete or current.

Patients with questions about their health should contact their own healthcare provider. In an emergency, call 911.

Sources, image credits and editorial policy

Discuss a testing program with InnovexLab

Review the panel that fits your patients, its specimen requirements, and how results and billing work.